Regeneron Asks FDA for Emergency Approval for Drug Taken by President Trump

The drugmaker Regeneron said on Wednesday evening that it had submitted an application to the Food and Drug Administration for emergency approval of the experimental antibody cocktail that President Trump had praised just hours earlier without evidence as a “cure” for the coronavirus. The company said that at first, access to the treatment would be extremely limited, with only enough doses for 50,000 patients, a far cry from the “hundreds of thousands” of doses that Mr. Trump said in a video released Wednesday he would soon be making available to Americans free of charge…

RELATED: Trump pushes Regeneron, Eli Lilly COVID-19 treatments for emergency authorizations

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s